Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
about
Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment.Preeclampsia and Pregnancy-Related Hypertensive DisordersMechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia.Assessing the Circulating Placental-Specific Anti-angiogenic Protein sFLT-1 e15a in Preeclampsia.Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies.Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis.Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.
P2860
Q33687481-BAE39BD0-B397-419F-9A13-9C58FC7EE15BQ36584747-AA0A00CD-1C26-4D61-A610-629A858AD8ADQ37136212-031B991F-3381-4D36-8D90-745526D6F196Q42099246-645CFDE5-3512-4C33-A8E1-F428BB8B2306Q46301098-4E0226A8-5693-4F90-A9CF-13026ACE261FQ46342648-873B6851-91E3-4465-B560-57BF75E3D88CQ47176561-5F588CDC-487E-4473-9EFA-2FCD3A1D53C4Q47799852-E1BF559E-1F55-4B5E-BC67-6E3EB23A7B36Q50017347-02BE5E6D-2CB2-4348-BC22-5E3C84A2B70AQ50343421-3E8B6BF9-BA61-4974-970D-A0F155531289
P2860
Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Placental-Specific sFLT-1 e15a ...... d Has Antiangiogenic Activity.
@en
type
label
Placental-Specific sFLT-1 e15a ...... d Has Antiangiogenic Activity.
@en
prefLabel
Placental-Specific sFLT-1 e15a ...... d Has Antiangiogenic Activity.
@en
P2093
P50
P1433
P1476
Placental-Specific sFLT-1 e15a ...... nd Has Antiangiogenic Activity
@en
P2093
Laura Tuohey
Natalie Binder
Ping Cannon
Roxanne Hastie
P304
P356
10.1161/HYPERTENSIONAHA.115.05883
P407
P577
2015-09-28T00:00:00Z